Nucleotide and nucleoside-based drugs: past, present, and future

Graphical abstract

• Publication year

  2022

• Venue

  Saudi Journal of Biological Sciences

• Publication date

  2022-10-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.sjbs.2022.103481PMID 36389209PMCID 9641258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture

  2022influential reference
• 1'-Ribose cyano substitution allows Remdesivir to effectively inhibit nucleotide addition and proofreading during SARS-CoV-2 viral RNA replication.

  2021cited by this paper
• Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice

  2021cited by this paper
• Overview of Biologically Active Nucleoside Phosphonates

  2021cited by this paper
• Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial

  2021cited by this paper
• Recent advances made in the synthesis of small drug molecules for clinical applications: An insight

  2021cited by this paper
• Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)

  2020cited by this paper
• Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

  2020influential reference
• Role of 1’-Ribose Cyano Substitution for Remdesivir to Effectively Inhibit Nucleotide Addition and Proofreading in SARS-CoV-2 Viral RNA Replication

  2020cited by this paper
• Current pharmacological treatments for COVID‐19: What's next?

  2020cited by this paper
• Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

  2020cited by this paper
• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

  2020influential reference
• Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection

  2020cited by this paper
• Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19

  2020cited by this paper
• Nucleotide analogues as inhibitors of SARS‐CoV Polymerase

  2020cited by this paper
• Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

  2020cited by this paper
• Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

  2020cited by this paper
• Nucleotide Analogues as Inhibitors of Viral Polymerases

  2020cited by this paper
• Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

  2020cited by this paper
• The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

  2020cited by this paper
• Antivirals in medical biodefense

  2020cited by this paper
• Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

  2020cited by this paper
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation

  2020influential reference
• Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19

  2020cited by this paper
• Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach

  2020cited by this paper
• Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

  2020cited by this paper
• Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19

  2020cited by this paper
• Nucleoside Analogues as Antibacterial Agents

  2019cited by this paper
• Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo

  2019cited by this paper
• Nucleoside analogues for the treatment of coronavirus infections

  2019cited by this paper
• Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus

  2018cited by this paper
• Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters

  2018influential reference
• Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses

  2018cited by this paper
• The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold

  2018cited by this paper
• Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses.

  2017cited by this paper
• Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

  2017cited by this paper
• Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction

  2017cited by this paper
• Efficacy of the broad‐spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model

  2017cited by this paper
• Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment

  2016cited by this paper
• BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease

  2016cited by this paper
• Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

  2016cited by this paper
• Sofosbuvir, a Significant Paradigm Change in HCV Treatment

  2015cited by this paper
• The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C

  2015cited by this paper
• Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.

  2015cited by this paper
• BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model

  2014cited by this paper
• Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

  2014cited by this paper
• Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

  2013cited by this paper
• The Holý Trinity: the acyclic nucleoside phosphonates.

  2013cited by this paper
• Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.

  2011cited by this paper
• Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus.

  2010cited by this paper
• Mizoribine: A New Approach in the Treatment of Renal Disease

  2009cited by this paper
• Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms

  2008cited by this paper
• Mizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study Group

  2008cited by this paper
• Nucleoside analogs: molecular mechanisms signaling cell death

  2008cited by this paper
• Mechanism of action of ribavirin in the treatment of chronic hepatitis C.

  2007influential reference
• Inhibition of Human Coronavirus NL63 Infection at Early Stages of the Replication Cycle

  2006cited by this paper
• Mechanism of action of interferon and ribavirin in treatment of hepatitis C

  2005cited by this paper
• Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus

  2005cited by this paper
• Tenofovir‐Related Nephrotoxicity: Case Report and Review of the Literature

  2004cited by this paper
• The metabolism of ribavirin in erythrocytes and nucleated cells.

  1990cited by this paper
• Treatment of hepatitis.

  1988cited by this paper
• Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide

  1972cited by this paper
• Design, synthesis, and broad spectrum antiviral activity of 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

  1972influential reference
• Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides.

  1972cited by this paper
• Pharmacogenomics and Personalized Medicine Dovepress Finally Sofosbuvir: an Oral Anti-hcv Drug with Wide Performance Capability

  year unknowncited by this paper

• Copper-Catalyzed Photocatalyst-Free Radical N -Glycosylation

  2026cites this paper
• A Comprehensive Review of Antimicrobial Drugs: Mechanisms of Action and Specific Targets in Microorganisms

  2025cites this paper
• A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection

  2025cites this paper
• Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID‐19: A Multicenter, Retrospective, Real‐World Study

  2025cites this paper
• Current trends in diagnostics, biomarker identification, and drug discovery targeting Monkeypox (Mpox)

  2025cites this paper
• Sulfur- and phosphorus-containing FDA approved drugs in the last five years (2020–2024): A journey among small molecules

  2025cites this paper
• Design, synthesis, and theoretical studies of sulfonylated purine derivatives as EGFR inhibitor

  2025cites this paper
• Frustrated Lewis Acid-Catalyzed C-N Coupling for the Stereoselective Synthesis of Nucleoside Analogs.

  2025cites this paper
• Patterns and characteristics of cranial nerve neuropathy in West Nile virus infection: a systematic review of cases reported globally

  2025cites this paper
• Application of Mass Spectrometry for Analysis of Nucleobases, Nucleosides and Nucleotides in Tea and Selected Herbs: A Critical Review of the Mass Spectrometric Data

  2024cites this paper
• Synthesis, antimicrobial, and in silico studies of C5′-O-substituted cytidine derivatives: cinnamoylation leads to improvement of antimicrobial activity

  2024cites this paper
• Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties

  2024cites this paper
• Biocatalytic Nucleobase Diversification of 4'-Thionucleosides and Application of Derived 5-Ethynyl-4'-thiouridine for RNA synthesis detection.

  2024cites this paper
• Exploring nucleoside analogs: key targets in the viral life cycle - advancing strategies against SARS-CoV-2

  2024cites this paper
• Regioselective Deacetylation in Nucleosides and Derivatives

  2024cites this paper
• Nucleot(s)ide Analogs for Chronic Hepatitis Virus Therapy: A Global Bibliometric Analysis (1986-2022)

  2024cites this paper
• Biochemical characterization of Mycobacterial RNA polymerases

  2024cites this paper
• Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives

  2023cites this paper
• Mpox (formerly monkeypox): pathogenesis, prevention and treatment

  2023cites this paper
• Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview

  2023cites this paper
• Recent Advances in Molecular Mechanisms of Nucleoside Antivirals

  2023cites this paper